A Transformative Period - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Transformative Period

Cornea, cataract, refractive, and anterior segment surgery remain at the forefront of ophthalmic innovation, yet several challenges persist that demand critical reflection and collaborative solutions. As we navigate 2025, a few key issues warrant our attention.

  • By

  • Lisa K. Feulner, MD, PhD

  • June 1, 2025

  • 3 min

Share

  • 1

    Corneal transplantation is evolving with lamellar techniques like DMEK and DALK, but accessibility remains uneven, especially in low-resource settings.

  • 2

    Keratoconus management has improved with corneal cross-linking, but standardizing treatment protocols for pediatric patients is still a concern.

  • 3

    Ocular surface disease, including dry eye, is recognized as a public health issue, worsened by screen time and environmental factors.

  • 4

    Research into inflammatory pathways and the microbiome suggests potential for targeted therapies in ocular surface disease management.

  • 5

    Technological advancements and interdisciplinary collaboration are driving a transformative period in corneal and anterior segment surgery.

Original Source(s)

A Transformative Period

  • by Lisa K. Feulner, MD, PhD

  • June 1, 2025

Related Content

Addressing the Gap in Keratoconus Diagnosis

Early screening and the new Epioxa treatment could transform keratoconus care.

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.

Advancing Keratoconus Care

Glaukos and Mitch Ibach, OD, FAAO, review how Epioxa is changing keratoconus care.